Tech Company Financing Transactions

CytomX Therapeutics Funding Round

On 6/17/2015, CytomX Therapeutics raised $70 million in Series D funding from Fidelity Management & Research Company, Casdin Capital and Cormorant Asset Management.

Transaction Overview

Announced On
6/17/2015
Transaction Type
Venture Equity
Amount
$70,000,000
Round
Series D
Investors

Fidelity Management & Research Company (Lead Investor)

Casdin Capital

Cormorant Asset Management

Deerfield Capital

Perceptive Advisors

Redmile Group

Tekla Capital Management

Venrock

Wellington Management Company

Proceeds Purpose
Proceeds from the financing will support the continued advancement of CytomX's pipeline of Probody therapeutics toward clinical studies, including a Precision cancer immunotherapy directed against PD-L1 and Probody drug conjugates against novel, first in class targets. The financing will also support the expansion of Probody research and development activities in the areas of T-cell agonists, bispecific antibodies and engineered T-cell therapies.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
151 Oyster Point Blvd. 400
San Francisco, CA 94080
USA
Email Address
Overview
CytomX (NASDAQ: CTMX) is unlocking the potential of antibody therapeutics in oncology by developing a novel therapeutic antibody class of highly targeted Probody therapeutics.
Profile
CytomX Therapeutics LinkedIn Company Profile
Social Media
CytomX Therapeutics Company Twitter Account
Company News
CytomX Therapeutics News
Facebook
CytomX Therapeutics on Facebook
YouTube
CytomX Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sean McCarthy
  Sean McCarthy LinkedIn Profile  Sean McCarthy Twitter Account  Sean McCarthy News  Sean McCarthy on Facebook
Chief Scientific Officer
Michael Kavanaugh
  Michael Kavanaugh LinkedIn Profile  Michael Kavanaugh Twitter Account  Michael Kavanaugh News  Michael Kavanaugh on Facebook
Vice President
Alison Joly
  Alison Joly LinkedIn Profile  Alison Joly Twitter Account  Alison Joly News  Alison Joly on Facebook
VP - Human Resources
Danielle Olander
  Danielle Olander LinkedIn Profile  Danielle Olander Twitter Account  Danielle Olander News  Danielle Olander on Facebook
VP - Manufacturing
Sridhar Viswanathan
  Sridhar Viswanathan LinkedIn Profile  Sridhar Viswanathan Twitter Account  Sridhar Viswanathan News  Sridhar Viswanathan on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/17/2015: ServiceTitan venture capital transaction
Next: 6/17/2015: Mapbox venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary